Autopsy report · NCT02700841
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
Cause of deathSlow enrollment
“Study terminated prematurely due to poor recruitment.”
Life of this trial
- Registered 3 years 10 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Conditions
- Plasma Cell Myeloma
- Interventions
- Melphalan; Peripheral Blood Stem Cell Transplantation--CD34 HSCT; Peripheral Blood Stem Cell Transplantation--AHSCT; T Cell-Depleted Hematopoietic Stem Cell Transplantation; Tetanus Toxoid Vaccine
- Participants
- 8
- Sites
- 1
- Countries
- United States
Trials that died the same way
- THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
“Study terminated due to slow recruitment.” - Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
“Study terminated due to inadequate recruitment” - A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
“Study was terminated early due to prolonged recruitment period.” - Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
“The study was terminated prematurely because of difficulty with recruiting.” - To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
“the study was early terminated due to lack of recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.